Malmö, Sweden

Joacim Elmén

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 99(Granted Patents)


Location History:

  • Malmö, SE (2013 - 2015)
  • Stockholm, SE (2012 - 2017)
  • Malmo, SE (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovation and Impact: The Contributions of Joacim Elmen

Introduction

Joacim Elmen, an esteemed inventor based in Malmö, Sweden, has made significant strides in the field of biotechnology. With a portfolio of five patents, his work primarily revolves around the development of novel oligonucleotides aimed at medical applications. His innovative approaches contribute greatly to the understanding and treatment of various diseases.

Latest Patents

Among Joacim Elmen's latest inventions are two notable patents titled "Micromirs" and "MICROMIRs." Both inventions involve very short heavily modified oligonucleotides specifically designed to target and inhibit microRNAs in vivo. These advancements hold considerable promise for their use in medicaments and pharmaceutical compositions, showcasing Elmen's commitment to addressing critical health challenges.

Career Highlights

Elmen's professional journey includes significant roles at well-respected companies in the pharmaceutical sector, particularly at Roche Innovation Center Copenhagen A/S and Santaris Pharma A/S. His experiences in these leading organizations have equipped him with the skills and insights necessary to drive innovation and impact in the field of biomedicine.

Collaborations

Throughout his career, Joacim has collaborated with prominent colleagues, including Susanna Obad and Sakari Kauppinen. These partnerships have facilitated the sharing of ideas and expertise, enhancing the development of groundbreaking technologies in the life sciences.

Conclusion

Joacim Elmen stands as a pivotal figure in the realm of biotech innovation, particularly through his work on oligonucleotides targeting microRNAs. His patents reflect a deep commitment to advancing medical science and improving therapeutic options. As the field continues to evolve, the contributions of inventors like Joacim will undoubtedly play a crucial role in shaping future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…